Skip to main content
. Author manuscript; available in PMC: 2013 Jul 22.
Published in final edited form as: Methods Mol Biol. 2013;963:303–317. doi: 10.1007/978-1-62703-230-8_18

Figure 2.

Figure 2

Intratumoral in vivo screening trial. The histogram depicts the mean tumor responsiveness for intratumoral injection of SBi931 (red bars) or vehicle only (black bars) every other day for 21 days. Asterisk denotes p < 0.05 when compared to vehicle only.